Applied DNA Sciences, Inc.: Applied DNA and EvviVax Announce Publication of Positive Preclinical Data for LinearDNA Platform Approach to Cancer Immunotherapy
- First Published Study Demonstrates LinearDNA Pan-Cancer and Colon Cancer Neoantigen Vaccines - - LinearDNA Vaccines Elicits Strong Antigen-specific Immune Responses and Significantly Reduces Tumor
Jamesa Hayward Luigi Aurisicchio United State Department Of Agriculture Sciences Inc Drug Administration Program Contact
Source: finanznachrichten.de